Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.